MedTrace Logo

Feasibility and Efficacy Study for a Pre-visit Lab Protocol for Adult Medicine Physicals

NCT05707364 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 301000

Last updated 2024-04-01

No results posted yet for this study

Summary

This is a research study evaluating the implementation of a clinic workflow to encourage pre-visit laboratory testing, such as blood work. The purpose of this research is to understand provider and patient satisfaction with clinic workflows to support pre-visit laboratory tests (blood work) for annual physical and wellness visits. Providers and staff at participating sites will be approached to fill out an anonymous survey regarding experiences with implementation of the pre-visit laboratory testing workflow. Additional data from NorthShore's Enterprise Data Warehouse (EDW) will be collected to assess the pre-lab test rate before implementation, at 6 months, and 12 months, in addition to provider and staff time efficiencies and patient satisfaction as assessed by surveys.

Conditions

  • Physical Examination
  • Diagnostic Tests, Routine
  • Burnout, Professional

Interventions

BEHAVIORAL

Pre-visit Lab Workflow

1. Based on buy-in from the providers/staff one or both of the practices below will be introduced into the clinic workflow to order pre-visit labs. 1. All procedures are within the standard of care, only the order of operations is being changed. After sharing lab results with patient from the most recent routine physical, physician records labs for the next calendar year in EMR. 2. Prior to appointment, Medical Assistant (MA) will review notes and orders to setup pre-visit labs. 2. Patient contacted to complete labs prior to the scheduled routine physical. 3. Resulted labs are triaged based on urgency. 4. After Visit Summary used to communicate about labs and surveys.

Sponsors & Collaborators

Principal Investigators

  • Nadim Ilbawi, MD · Endeavor Health

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-08
Primary Completion
2025-05-01
Completion
2025-05-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05707364 on ClinicalTrials.gov